CMPR
Cimpress plc
CMPR's fundamentals are mixed, but it looks cheap: trading at 17x earnings, below its usual 27x.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
CMPR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
CMPR's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CMPR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $36.09 | -36% |
| Current | 17x | $56.43 | — |
| Fair | 26x | $89.07 | +58% |
| Expensive | 60x | $202 | +258% |
Historical ranges are pointers, not guarantees.
CMPR has the edge over NBIS in the historical PE scenario, which offers more potential upside but is not a forecast.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
CMPR Forward outlook
There aren't enough analyst estimates for CMPR to show an outlook.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
CMPR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.38 | +145% |
| Q2 2026 | $3.79 | +553% |
| Q1 2026 | $1.85 | -68% |
| Q4 2025 | $0.97 | -84% |
| Q3 2025 | $1.38 | -76% |
| Q2 2025 | $0.58 | -91% |
| Q1 2025 | $5.80 | +78% |
| Q4 2024 | $5.98 | +291% |
CMPR has the edge over NBIS in the latest year-over-year earnings comparison.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
CMPR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $934.1M | +8.2% |
| Q2 2026 | $945M | +8.7% |
| Q1 2026 | $886.2M | +12% |
| Q4 2025 | $1B | +11% |
| Q3 2025 | $863.3M | +7.2% |
| Q2 2025 | $869.5M | +4.4% |
| Q1 2025 | $789.5M | +1.1% |
| Q4 2024 | $939.2M | +1.9% |
CMPR has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.8% | -2.9 points |
| Q2 2026 | 6.9% | -0.7 points |
| Q1 2026 | 5.5% | +0.4 points |
| Q4 2025 | 8.4% | -0.2 points |
| Q3 2025 | 5.7% | +0.8 points |
| Q2 2025 | 7.5% | -0.4 points |
| Q1 2025 | 5.1% | +0.1 points |
| Q4 2024 | 8.6% | -3.1 points |
CMPR's operating margin was 2.8% last quarter, down 2.9 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
CMPR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.1M | +$7.4M |
| Q2 2026 | $84.8M | -2.1% |
| Q1 2026 | -$39.5M | -$24.4M |
| Q4 2025 | $139.5M | -7.1% |
| Q3 2025 | -$1.3M | +$11.3M |
| Q2 2025 | $86.7M | -24% |
| Q1 2025 | -$15.1M | -$13.1M |
| Q4 2024 | $150.1M | -8.2% |
CMPR still generates free cash flow, though less than at its 2019 peak: $191M over the past year.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
CMPR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.3% | -842K shares |
| 1 year | -2.3% | -567K shares |
| 3 years | -9.6% | -2.6M shares |
| 5 years | -7.9% | -2.1M shares |
| Available history | -12% | -3.4M shares |
CMPR has 24M diluted shares, down 2.3% from a year ago, with $47M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $21.9M |
| Q4 2025 | $25.5M |
| Q3 2025 | $2.7M |
| Q2 2025 | $20.8M |
| Q1 2025 | $3.9M |
| Q4 2024 | $42.4M |
CMPR spent $47M buying back its own shares over the past year, down 32% from the year before.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over CMPR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
CMPR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.9x | Elevated |
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.8x | Elevated |
| Q4 2024 | 3.7x | Elevated |
CMPR's net debt is about 3.9 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
CMPR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.6 | Oversold |
| Stochastic | 2.6 | Oversold |
CMPR's weekly RSI is 29 (oversold) and its Stochastic is 3 (oversold).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CMPR PE vs Communication Services Sector
| Metric | CMPR | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 16x | 1.3% above |
| PE % | 38 | 26 | 12 pts above |
CMPR has the edge over NBIS on valuation relative to its sector.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
CMPR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.4 | 19% below |
| 20 week MA | $83.6 | 32% below |
| 50 week MA | $81.5 | 31% below |
| 100 week MA | $68.4 | 18% below |
| 200 week MA | $69.6 | 19% below |
NBIS has stronger trend alignment. CMPR is above 0 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
CMPR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $126.4 | $86.6 | -31% |
| 2021 | $86.6 | $69.8 | -19% |
| 2022 | $69.8 | $27.1 | -61% |
| 2023 | $27.1 | $80.1 | +196% |
| 2024 | $80.1 | $72.2 | -9.8% |
| 2025 | $72.2 | $69.2 | -4.1% |
| 2026 YTD | $69.2 | $56.4 | -18% |
CMPR's yearly returns have swung widely, from +196% in 2023 to −61% in 2022. It's down 18% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over CMPR on returns for 2026, with the stronger performance.